Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 28, 2013

Takeda Pharmaceutical Co., Ltd. et al v. Mylan Inc. et al

Track this case

Case Number:

5:13-cv-04002

See also:

Court:

California Northern

Nature of Suit:

Patent

Judge:

Lucy H. Koh

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 05, 2014

    Takeda Barred From Doubling Up Patent Claims In Drug Case

    A California federal judge has tossed Takeda Pharmaceutical Co. Ltd.'s claim seeking declaratory judgment that Mylan Inc.'s planned generic version of the acid reflux drug Dexilant will infringe its patents, saying it "serves no purpose" since Takeda also alleges infringement under the Hatch-Waxman Act.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login